
Don't Qualify For The Current Chase Sapphire Preferred 100K Offer? Here's Why It's Worth It To Be An Authorized User
Becoming an authorized user on someone else's Chase Sapphire Preferred® Card can be a win-win situation for all. Here's why.
The Chase Sapphire Preferred® Card earns Chase Ultimate Rewards®, a flexible rewards currency that can be used as cash back, to book travel through Chase Travel℠ at a 25% increase in value or transferred to one of Chase's hotel and airline travel partners. The latter two are some of the best redemption options for those looking to use their rewards for travel and are a main driver behind the card's overall value.
The Sapphire Preferred earns rewards at a rate of 5 points per dollar on travel purchased through Chase Travel℠, 3 points per dollar on dining, select streaming services, and online grocery purchases (excluding Walmart, Target and wholesale clubs), 2 points per dollar on all other travel purchases and 1 point per dollar on other purchases. That's a solid rewards rate for a card with a $95 annual fee. If you're added as an authorized user on someone's card, you'll both earn rewards at that same rate, and all the earnings will be combined under the primary cardholder's account. This can streamline your combined rewards-earning strategy and help you work toward a common goal.
Chase allows points pooling between two household members, which opens up a lot of ways to make the most of your spending and points redemption strategy. For example, let's say Card Member A has a Chase Sapphire Preferred card and adds Card Member B as an authorized user. Card Member B has a Chase Freedom Unlimited®, which earns 5% cash back on travel purchased through Chase Travel℠, 3% cash back on eligible dining and drugstores and 1.5% on all other purchases.
Card Member A is added to Card Member B's Freedom Unlimited as an authorized user. If both parties used their Sapphire Preferred on travel and dining and their Freedom Unlimited on everything else, they'd earn between 1.5 points to 5 points on every purchase, allowing them to work together to build up a stash.
The Chase Sapphire Preferred makes it easy for novices and experienced travel rewards redeemers alike to squeeze more value out of their points than if those rewards are used for cash back. Choosing to redeem Ultimate Rewards for cash back gives you a value of 1 cent per point. But the Chase Sapphire Preferred gives you two ways to make more out of your stash.
Both the primary cardholder and the authorized user can book travel with rewards directly through Chase Travel, and the points will be worth 25% more—a valuable feature that makes it one of the best Chase cards on the market.
In other words, book a $125 flight through Chase Travel, and it will only cost 10,000 points. Compare that to using cash back to pay for your flight. In that scenario, it would cost you 12,500 points since a point is worth 1 cent each when taken as cash.
The secret sauce to travel rewards is when issuers offer travel transfer partners. The Chase Sapphire Preferred is one of three Chase cards that allow you to transfer your rewards to Chase's travel transfer partners. The other two are the Chase Sapphire Reserve® and the Ink Business Preferred® Credit Card.
Transferring rewards directly to travel partners can save you a lot of points, so this is a worthwhile perk for anyone seeking a travel card.
For instance, if we compare the price of a JetBlue (one of Chase's partners) flight Thanksgiving week in November 2025, one way from Fort Lauderdale (FLL) to New York's JFK airport, the lowest cash price is $209.
Since bookings made through Chase Travel are based on the cash price, it would cost you 16,720 Ultimate Rewards points with the Chase Sapphire Preferred's 25% points boost to book this flight through Chase Travel.
That same flight, when booked with points through JetBlue, requires just 13,900 TrueBlue points.
This means you can save 2,820 points by transferring your Ultimate Rewards to JetBlue TrueBlue and booking that way. It may not seem like a huge difference, but the savings can really add up across multiple tickets or travel bookings.
Good news here for authorized users of the Chase Sapphire Preferred: Both primary users and authorized users can transfer their rewards directly to one of Chase's travel transfer partners.
Chase has a widely known (but unpublished) rule known as the '5/24 rule'. This means Chase will not approve you for a new credit card if you have applied for five or more personal credit cards from any issuer within the previous 24 months. If you are over 5/24 but want to utilize the Sapphire Preferred's benefits, it can make sense to become an authorized user on someone else's card.
Related to this, you also cannot earn a welcome bonus on either the Chase Sapphire Preferred or the Chase Sapphire Reserve if you've earned a welcome bonus on any Sapphire card within the previous 48 months or currently own a Sapphire card as a primary card member. Someone who appreciates the benefits of their Chase Sapphire Preferred but wants an opportunity to earn a welcome bonus on the card down the line can go the authorized user route.
The Chase Sapphire Preferred card charges an annual fee of $95, but there's no charge for authorized user cards. Saving that $95 is a nice perk of adding an authorized user instead of having them get their own card.
It's worth noting that most financial institutions no longer offer joint credit card accounts, where both parties share responsibility for the account. So, for couples who want to share a credit card account, having one person as the primary cardholder and the other as an authorized user is the next best thing.
The Chase Sapphire Preferred packs valuable travel protections into a card with an annual fee under $100. The card comes with primary auto rental coverage, trip cancellation and interruption coverage, baggage delay insurance and trip delay reimbursement. The card also offers purchase protection and extended warranty coverage.
Anyone who travels is likely to experience a delay or an unexpected change in plans at some point, so these perks can add value. Additionally, the purchase protections can also save you a bundle if something you bought while traveling breaks or is stolen and you can't return to the merchant for assistance. Authorized Sapphire Preferred users get to enjoy these benefits on their cards.
DoorDash is an online food and grocery delivery service. DashPass is DoorDash's subscription service that offers $0 delivery fees and lower service fees on eligible orders in exchange for a $9.99 monthly plan.
The Chase Sapphire Preferred card offers both primary cardholders and authorized users complimentary DashPass access for a minimum of one-year when you activate the subscription by December 31, 2027. That could add up to major savings for those who frequently use the service.
Becoming an authorized user on the Chase Sapphire Preferred card has loads of benefits. For those chasing a particular card strategy, it can make sense to become an authorized user rather than applying for the card outright. Plus, the opportunity to save money and work toward a shared rewards-earning strategy can help you and the primary cardholder reach shared travel goals.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
40 minutes ago
- Business Wire
Sammons Financial Group Employees Direct $175,000 to Iowa Charities
WEST DES MOINES, Iowa--(BUSINESS WIRE)-- Sammons ® Financial Group, Inc. announced the results of its 2025 Community Outreach Program. Sammons Financial Group employees selected 25 organizations to receive a total of $175,000 in financial support. Recipient charities were invited to the company's West Des Moines headquarters to further connect with employees about their organization and mission. The initiative, started in 2018, empowers employees to nominate their favorite local charities to be considered for a financial grant from Sammons Financial Group. The employees who choose to make nominations are given the opportunity to educate their coworkers on the mission of the organization and why they are passionate about it. Employees then vote for the organizations they would like the company to support financially. 'Our employees selected this year's recipients because of the excellent work they do in our community,' said Casey Decker, West Des Moines site leader and Chief Operating Officer at Sammons Financial Group. 'We're proud to support these organizations elevating the quality of life in Central Iowa.' The following organizations received funding from the 2025 Community Outreach Program: Aheinz57 American Cancer Society (Iowa Chapter) American Lung Association of Iowa American Parkinson Association Iowa Chapter Animal Rescue League of Iowa Building Brave Teams Camp Fire of Iowa Combat Vets Motorcycle Association Iowa Chapter 39-1 Des Moines Refugee Support Focuss Four Oaks Foster and Adoption Support Great Plains Pointer Rescue Hope Ministries Iowa Donor's Network Iowa Jobs for America's Graduates Kid Hope USA Leukemia and Lymphoma Society of Iowa Mason's Lighthouse Peace Creek Animal Sanctuary and Rescue SEEDS Shriner's Children's Hospital in partnership with Blank Children's Hospital Sleep in Heavenly Peace The Supply Hive Urban Bicycle Food Ministry Waypoint Resources The Community Outreach Program is one part of Sammons Financial Group's longstanding commitment to its communities. In 2024, the company donated $4.7 million to local charities through its various charitable giving programs. West Des Moines is home to about 1,000 on-site and remote employees. A similar program is held each year in the Sioux Falls office, which has 600 employees. About Sammons ® Financial Group, Inc. Sammons Financial Group ® helps families and businesses by empowering futures and changing lives. Sammons Financial Group is employee owned with member companies that are among the most enduring and stable in the financial services industry. Our member companies include Midland National ® Life Insurance Company (including Sammons ® Corporate Markets); North American Company for Life and Health Insurance ®; Sammons Institutional Group ® (including Midland Retirement Distributors ® and Sammons Retirement Solutions ®) and Sammons Wealth Management Group. Committed to our communities, Sammons Financial Group is Midwest-based, with offices in Iowa, Illinois, Minnesota, North Dakota, Ohio, and South Dakota.
Yahoo
2 hours ago
- Yahoo
$1M Lottery Powerball ticket won in Pa.
(WBRE/WYOU) — A lucky lottery player has won $1 million off a Powerball ticket in Pennsylvania. A Pennsylvania Lottery retailer in Carbon County sold a Powerball® ticket worth $1 million for the Monday, August 4, drawing. The ticket matched five of the five white balls drawn, 8-9-19-31-38, but not the red Powerball® 21, to win $1 million. $1M won off $20 lottery scratch-off ticket in Pa. Boyer's Food Markets in Lansford Boro will receive a $5,000 bonus for selling the winning ticket. Winners are not known until prizes are claimed and tickets are validated. Pennsylvania Lottery Powerball® winners have one year from the drawing date to claim prizes. Winning tickets purchased at a Lottery retailer should immediately be signed on the back. Online winnings automatically appear in a player's account after the claim has been processed. Players may visit for more information about how to file a claim. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Yahoo
3 hours ago
- Yahoo
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology developed to address blood pressure instability after spinal cord injury (SCI). Managing blood pressure instability is a major unmet need after SCI, with a significant impact on cardiovascular health and quality of life. Approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe are expected to participate. EINDHOVEN, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the ARC-IM System. With this approval, the Company can initiate the Empower BP pivotal study to assess the safety and efficacy of its implantable spinal stimulation system to address blood pressure instability after SCI. Empower BP is the Company's second global pivotal study, and the first to evaluate the implantable ARC-IM System. The randomized, double-blinded, sham-controlled study is expected to involve approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe, with first patient enrollment anticipated before the end of the year. The study will target participants with injuries at spinal cord levels C2-T6, injury severities of AIS A-D, and blood pressure instability characterized by chronic orthostatic hypotension (OH) and episodes of autonomic dysreflexia (AD). 'This is an important milestone for ONWARD and the SCI community,' said Dave Marver, CEO of ONWARD. 'Our ARC-IM System is designed to address several unmet needs, including blood pressure instability which is a major recovery target after spinal cord injury. With this IDE approval, we continue to advance our innovation pipeline and inspire realistic hope in restoring autonomic functions and independence after SCI and other movement disabilities.' Over 50% of people with SCI experience blood pressure instability, affecting nearly 350,000 people in the US and Europe.1 Blood pressure instability and persistent low blood pressure can threaten neurological recovery and negatively impact cardiovascular health and quality of life. The most frequent symptoms include dizziness, lightheadedness, blurred vision and fatigue.2 'Blood pressure instability, especially chronic low blood pressure, is one of the most hidden and unrecognized functional complications of spinal cord injury,' explains Dr. James Guest, neurosurgeon and Professor of Neurological Surgery at the University of Miami. 'It leaves people feeling unwell and can significantly impact their overall quality of life. Blood pressure instability also increases the risk of cardiovascular disease, making addressing this unmet need critical for improving the long-term outcomes of SCI.' The ONWARD ARC-IM System is an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. It is the first neuroprosthetic system designed to manage blood pressure instability in people with SCI. It comprises the implanted ONWARD Neurostimulator (IPG) and the ARC-IM Thoracic Lead. The ARC-IM Thoracic Lead is optimized for surgical placement in a specific region of the thoracic spinal cord, called the 'Hemodynamic Hotspot'. The location was first discovered by the Company's research partners at the Swiss Federal Institute of Technology Lausanne (EPFL), Centre Hospitalier Universitaire Vaudois (CHUV), and the University of Calgary in a study published in Nature in January 2021.3 In December 2022, the Company announced positive top-line interim clinical results from its feasibility studies showing improved blood pressure regulation and improved hemodynamic stability after SCI. In addition to immediate and sustained improved blood pressure levels, participants taking anti-hypotension drugs prior to the study significantly reduced or discontinued their medication. Participants also reported improved general well-being and a reduction in orthostatic hypotension, including reduced dizziness and increased energy. Detailed interim results from these studies are expected to be published later this year. Managing blood pressure instability is among the major unmet needs for which the FDA has awarded the Company one of its 10 Breakthrough Device Designations. This award is reserved for novel, cutting-edge therapies addressing unmet needs and provides potential regulatory and reimbursement benefits. To stay informed about ONWARD's research studies, technologies, and the availability of therapies in your area, please complete this webform. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries, and other movement disabilities. Building on over a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company developed ARC Therapy. It has subsequently been awarded 10 Breakthrough Device designations from the FDA. The Company's ARC-EX® System is cleared for commercial sale in the US. The Company is also developing an investigational implantable system called ARC-IM, which can be paired with a brain-computer interface (BCI) to restore thought-driven movement. Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD) and its US ADRs can be traded on OTCQX (ticker: ONWRY). For more information, please visit For Media Inquiries: Sébastien Cros, VP Communications media@ For Investor Inquiries: investors@ Notes and references: 1. Katzelnick CG et al. Blood Pressure Instability in Persons With SCI: Evidence From a 30-Day Home Monitoring Observation. Am J Hypertens. 2019 Sep 24;32(10):938-944 2. Carlozzi, N. E. et al. Impact of blood pressure dysregulation on health-related quality of life in persons with spinal cord injury: development of a conceptual model. Arch. Phys. Med. Rehabil. 94, 1721–1730 (2013) 3. Squair, J.W. et al. Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury. Nature 590, 308–314 (2021) Forward-Looking Statements Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data